Published in AIDS on January 01, 1995
Maintaining the integrity of human immunodeficiency virus sequence databases. J Virol (1996) 2.68
Evolutionary mechanisms and population dynamics of the third variable envelope region of HIV within single hosts. Proc Natl Acad Sci U S A (1997) 2.35
Infection of primary human microglia and monocyte-derived macrophages with human immunodeficiency virus type 1 isolates: evidence of differential tropism. J Virol (1996) 1.47
Cross-linking of Fas by antibodies to a peculiar domain of gp120 V3 loop can enhance T cell apoptosis in HIV-1-infected patients. J Exp Med (1996) 0.81
Infection of SK-N-MC cells, a CD4-negative neuroblastoma cell line, with primary human immunodeficiency virus type 1 isolates. J Virol (1996) 0.78
"Research participants want to feel they are better off than they were before research was introduced to them": engaging cameroonian rural plantation populations in HIV research. BMC Int Health Hum Rights (2012) 0.76
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet (2000) 5.49
Epidemiological basis for clinical diagnosis of childhood malaria in endemic zone in West Africa. Lancet (1991) 5.11
Transmission of antiretroviral-drug-resistant HIV-1 variants. Lancet (1999) 3.43
Turnover of CD4+ and CD8+ T lymphocytes in HIV-1 infection as measured by Ki-67 antigen. J Exp Med (1998) 3.24
The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan. Antivir Ther (2000) 3.14
Acute HIV infection: impact on the spread of HIV and transmission of drug resistance. AIDS (2001) 2.42
The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia. Proc Natl Acad Sci U S A (1997) 2.24
Dietetic guidelines on food and nutrition in the secondary prevention of cardiovascular disease - evidence from systematic reviews of randomized controlled trials (second update, January 2006). J Hum Nutr Diet (2006) 2.09
Nosocomial outbreak of multiple bloodborne viral infections. J Infect Dis (2001) 1.89
Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trial. AIDS (2003) 1.76
Rapid and sensitive detection of enteroviruses in specimens from patients with aseptic meningitis. J Clin Microbiol (1996) 1.67
Switch to unusual amino acids at codon 215 of the human immunodeficiency virus type 1 reverse transcriptase gene in seroconvertors infected with zidovudine-resistant variants. J Virol (1998) 1.65
Detection of low HIV-1 RNA levels in plasma. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 1.65
Emergence delirium in a child given oral midazolam for conscious sedation. Ann Emerg Med (1994) 1.63
Clinical relevance of cytomegalovirus viraemia(*,†). HIV Med (2011) 1.55
Hepatitis C virus in patients with cryoglobulinemia type II. J Infect Dis (1990) 1.50
Infection of primary human microglia and monocyte-derived macrophages with human immunodeficiency virus type 1 isolates: evidence of differential tropism. J Virol (1996) 1.47
Prevalence and incidence rate of HIV, hepatitis B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995. AIDS (1998) 1.46
The dental management of patients with natural rubber latex allergy. Br Dent J (1998) 1.44
Decay of cell-associated HIV-1 DNA correlates with residual replication in patients treated during acute HIV-1 infection. AIDS (2000) 1.44
Impact of drug resistance mutations on virologic response to salvage therapy. Swiss HIV Cohort Study. AIDS (1999) 1.44
[Post-exposure HIV prevention: eligibility of patients recently infected by sexual exposure]. Schweiz Med Wochenschr (1999) 1.40
Emergence of Acquired HIV-1 Drug Resistance Almost Stopped in Switzerland: A 15-Year Prospective Cohort Analysis. Clin Infect Dis (2016) 1.39
Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4. J Clin Invest (1992) 1.38
Sexual transmission during the incubation period of primary HIV infection. JAMA (2001) 1.37
Differential effects of omeprazole and pantoprazole on the pharmacodynamics and pharmacokinetics of clopidogrel in healthy subjects: randomized, placebo-controlled, crossover comparison studies. Clin Pharmacol Ther (2010) 1.36
Ignition and explosion risks of nanopowders. J Hazard Mater (2010) 1.34
Loss of antibodies against hepatitis C virus in HIV-seropositive intravenous drug users. AIDS (1990) 1.33
Species- and stage-specific antigens in exoerythrocytic stages of Plasmodium falciparum. Am J Trop Med Hyg (1984) 1.30
Updated European recommendations for the clinical use of HIV drug resistance testing. Antivir Ther (2004) 1.28
The diagnosis of malaria infection using a solid-phase radioimmunoassay for the detection of malaria antigens. Application to the detection of Plasmodium berghei infection in mice. Parasitology (1980) 1.28
Resistance to nucleoside analog reverse transcriptase inhibitors mediated by human immunodeficiency virus type 1 p6 protein. J Virol (2001) 1.22
Severity and prognosis of acute human immunodeficiency virus type 1 illness: a dose-response relationship. Clin Infect Dis (1998) 1.18
Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues. Antimicrob Agents Chemother (2000) 1.18
High frequency of non-B subtypes in newly diagnosed HIV-1 infections in Switzerland. J Acquir Immune Defic Syndr (1999) 1.17
Response of HIV RNA to didanosine as a predictive marker of survival. AIDS (1995) 1.15
Cell-associated HIV-1 RNA in blood as indicator of virus load in lymph nodes. The Swiss HIV Cohort Study. J Infect Dis (1999) 1.14
Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome. Medicine (Baltimore) (1992) 1.11
Time of initiation of antiretroviral therapy: impact on HIV-1 viraemia. The Swiss HIV Cohort Study. AIDS (2000) 1.10
Hepatitis C: a possible etiology for cryoglobulinaemia type II. Clin Exp Immunol (1992) 1.07
In vivo time course of synthesis and processing of major schizont membrane polypeptides in Plasmodium falciparum. Mol Biochem Parasitol (1986) 1.07
The Drosophila teashirt homeotic protein is a DNA-binding protein and modulo, a HOM-C regulated modifier of variegation, is a likely candidate for being a direct target gene. Mech Dev (1996) 1.05
Detection of human immunodeficiency virus type 1 (HIV-1) RNA in pools of sera negative for antibodies to HIV-1 and HIV-2. J Clin Microbiol (1998) 1.05
Chronic destructive lung disease associated with a novel mycobacterium. Am J Respir Crit Care Med (1994) 1.03
Mutations in SDCCAG8/NPHP10 Cause Bardet-Biedl Syndrome and Are Associated with Penetrant Renal Disease and Absent Polydactyly. Mol Syndromol (2011) 1.03
Protein encapsulation within polyethylene glycol-coated nanospheres. I. Physicochemical characterization. J Biomed Mater Res (1998) 1.02
Prognostic value of viremia in patients with long-standing human immunodeficiency virus infection. Swiss HIV Cohort Study Group. J Infect Dis (1996) 1.02
Growth-deficient mycobacteria in patients with AIDS: diagnosis by analysis of DNA amplified from blood or tissue. Clin Infect Dis (1995) 1.02
Incubation time of acute human immunodeficiency virus (HIV) infection and duration of acute HIV infection are independent prognostic factors of progression to AIDS. J Infect Dis (2000) 1.01
Peritoneal cytology: impact on disease-free survival in clinical stage I endometrioid adenocarcinoma of the uterus. Cancer Lett (2001) 0.99
Human T cell activation. Synergy between CD73 (ecto-5'-nucleotidase) and signals delivered through CD3 and CD2 molecules. J Immunol (1990) 0.98
Genetic polymorphisms and the impact of a higher clopidogrel dose regimen on active metabolite exposure and antiplatelet response in healthy subjects. Clin Pharmacol Ther (2011) 0.98
[Early diagnosis of primary HIV infections: using a combined screening test (p24 antigen and anti-HIV antibodies)]. Schweiz Med Wochenschr (1999) 0.95
The Drosophila tumor suppressor gene lethal(2)giant larvae is required for the emission of the Decapentaplegic signal. Development (2001) 0.94
Comprehensive classification of symptoms and signs reported among 218 patients with acute HIV-1 infection. J Acquir Immune Defic Syndr (1999) 0.94
Behavioural changes in intravenous drug users in Geneva: rise and fall of HIV infection, 1980-1989. AIDS (1990) 0.94
Expression of human IL 1 alpha and beta messenger RNAs and IL 1 activity in human peripheral blood mononuclear cells. J Mol Cell Immunol (1987) 0.93
Identification and expression in Escherichia coli of merozoite stage-specific genes of the human malarial parasite Plasmodium falciparum. Proc Natl Acad Sci U S A (1984) 0.93
A placebo-controlled trial of didanosine plus stavudine, with and without hydroxyurea, for HIV infection. The Swiss HIV Cohort Study. AIDS (1998) 0.93
Epidemiology of vertically transmitted HIV-1 infection in Switzerland: results of a nationwide prospective study. Swiss Neonatal HIV Study Group. Eur J Pediatr (1992) 0.92
High levels of circulating RNA in patients with symptomatic HIV-1 infection. AIDS (1993) 0.91
Mother to child transmission of zidovudine-resistant HIV-1. Lancet (1995) 0.91
Human herpesvirus-6 variant A encephalomyelitis. Neurology (2008) 0.91
Differential effects of in vitro mycoplasma infection on interleukin-1 alpha and beta mRNA expression in U937 and A431 cells. J Biol Chem (1988) 0.90
Acute human immunodeficiency virus type 1 disease as a mononucleosis-like illness: is the diagnosis too restrictive? Clin Infect Dis (1997) 0.90
Molecular and serological analysis of the epidemiology of myxoma virus in rabbits. Vet Microbiol (2009) 0.90
Regulation of interleukin-1ra, interleukin-1 alpha, and interleukin-1 beta production by human alveolar macrophages with phorbol myristate acetate, lipopolysaccharide, and interleukin-4. Am J Respir Cell Mol Biol (1993) 0.89
Antigen-specific and MHC-restricted Plasmodium falciparum-induced human T lymphocyte clones. J Immunol (1986) 0.89
Virological and immunological effects of combination antiretroviral therapy with zidovudine, lamivudine, and indinavir during primary human immunodeficiency virus type 1 infection. J Infect Dis (2000) 0.88
Hepatitis C virus acute exacerbation during chemotherapy and radiotherapy for oesophageal carcinoma. Ann Oncol (1994) 0.87
Foscarnet decreases human immunodeficiency virus RNA. J Infect Dis (1995) 0.86
Cytochrome P450-mediated oxidation of glucuronide derivatives: example of estradiol-17beta-glucuronide oxidation to 2-hydroxy-estradiol-17beta-glucuronide by CYP 2C8. Drug Metab Dispos (2004) 0.86
Early and prolonged decrease of viremia in HIV-1-infected patients treated with didanosine. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 0.86
Human immunodeficiency virus DNA amplification and serology in blood donors. Blood (1990) 0.86
Strong serological responses and HIV RNA increase following AS03-adjuvanted pandemic immunization in HIV-infected patients. HIV Med (2011) 0.86
Incident Hepatitis C Virus Infections in the Swiss HIV Cohort Study: Changes in Treatment Uptake and Outcomes Between 1991 and 2013. Open Forum Infect Dis (2015) 0.86
Obesity Trends and Body Mass Index Changes After Starting Antiretroviral Treatment: The Swiss HIV Cohort Study. Open Forum Infect Dis (2014) 0.85
Genetic polymorphism of CCR5 gene and HIV disease: the heterozygous (CCR5/delta ccr5) genotype is neither essential nor sufficient for protection against disease progression. Swiss HIV Cohort. Eur J Immunol (1997) 0.85
Strong Impact of Smoking on Multimorbidity and Cardiovascular Risk Among Human Immunodeficiency Virus-Infected Individuals in Comparison With the General Population. Open Forum Infect Dis (2015) 0.84
Prevalence of etravirine mutations and impact on response to treatment in routine clinical care: the Swiss HIV Cohort Study (SHCS). HIV Med (2009) 0.84